Marfan’s syndrome with aortic valve endocarditis

S, Jaiswal; BS, Magar; M, Poudel; LN, Joshi; A, Neupane; DB,  Karki

Publication:
Marfan’s syndrome with aortic valve endocarditis

creativeworkseries.issn	1812-2027
dc.contributor.author	S, Jaiswal
dc.contributor.author	BS, Magar
dc.contributor.author	M, Poudel
dc.contributor.author	LN, Joshi
dc.contributor.author	A, Neupane
dc.contributor.author	DB, Karki
dc.date.accessioned	2025-07-15T09:21:25Z
dc.date.available	2025-07-15T09:21:25Z
dc.date.issued	2004
dc.description.abstract	Marfan’s syndrome is an Autosomal dominant disorder of the connective tissues resulting in abnormalities of the musculoskeletal system, cardiovascular system and eyes. It has a prevalence of 1 in 100,000 population1 and occurs in all ethnic groups. It may be familial or due to new mutation (30%), in the fibrillin gene on arm of chromosome 15. It is estimated that one person in every 3000-5000 has Marfan’s syndrome may have cardiovascular abnormalities and may be complicated by infective endocartditis. About 90% of Marfan patients will develop cardiac complications2. The patient under discussion has musculoskeletal (Tall stature, reduced upper-lower segment ratio, arm-span to height ratio >1.05, high arched palate) and Cardiovascular features (Severe aortic regurgitation complicated with infective endocarditis) Key words: Marfan’s Syndrome, Autosomal dominant, Aortic Regurgitation, Infective Endocarditis
dc.identifier.uri	https://hdl.handle.net/20.500.14572/248
dc.language.iso	en_US
dc.publisher	Kathmandu University
dc.title	Marfan’s syndrome with aortic valve endocarditis
dc.type	Article
dspace.entity.type	Publication
local.article.type	Case Report
oaire.citation.endPage	233
oaire.citation.startPage	230
relation.isJournalIssueOfPublication	6b967c67-bdab-4ad5-8d9f-e5c8d1ee7279
relation.isJournalIssueOfPublication.latestForDiscovery	6b967c67-bdab-4ad5-8d9f-e5c8d1ee7279
relation.isJournalOfPublication	a782b7ff-cf89-4178-ad1c-11ed89cfe1bd